# CIBINQO
> **NDA213871** · New Drug Application · Sponsor: PFIZER · Approved 2022-01-14
## Drug
- **FDA Application Number:** NDA213871
- **Application type:** New Drug Application
- **Brand name:** CIBINQO
- **Generic name:** ABROCITINIB
- **Active ingredients:** ABROCITINIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PFIZER
- **Manufacturer:** U.S. Pharmaceuticals
- **First approval:** 2022-01-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213871)
---
*AI Analytics · CC0 1.0*